IRVINE, Calif., Sept. 17, 2007 (PRIME NEWSWIRE) -- "A recent acquisition by Guardian Technologies should significantly hasten Guardian Technologies International, Inc's (OTCBB:GDTI) scheduled release of innovative medical imaging Signature Mapping products, designed to materially improve a radiologist's ability to detect and treat targeted diseases," stated SmallCap Sentinel analyst D.R. Clark.
An informational report of interest to investors in Guardian Technologies International, Inc. as well as L-1 Identity Solutions, Inc. (NYSE:ID), Cerner Corp. (Nasdaq:CERN), Pointer Telocation Ltd. (Nasdaq:PNTR), is available at http://www.trilogy-capital.com/tcp/guardian/factsheet.html
"This is a watershed event for the company and its followers," Clark added. "Guardian has agreed to acquire iC Works software technology from Virginia-based Zinon Company in a move that is expected to accelerate the company's planned FDA clinical trials, potentially advancing by as much as one year possible federal approval for a broad range of health care applications. Investors who bought into the prospect of potential FDA approvals may find their timeframe has greatly decreased."
About Guardian Technologies International
The impact of Guardian's industry-first computer aided detection technologies are immediate and profound for helping to eliminate human error in both the Homeland Security and the Medical Industry sectors. The Company's software solutions can be seamlessly installed to compliment existing imaging devices, such as baggage scanners and medical MRI, to scan the contents of any image and immediately identify items of interest not easily discernable by the human eye. Guardian's technology and product development partnerships include a Cooperative Research and Development Agreement (CRDA) with the U.S. Department of Homeland Security-Science and Technology Directorate.
For investor-specific information, visit http://www.trilogy-capital.com/tcp/guardian.
To view current stock quotes and news, visit http://www.trilogy-capital.com/tcp/guardian/quote.html.
Individuals may register to receive future reports at: http://stockupticks.com/register.html
To have your company featured in StockUpTicks.com or SmallCap Sentinel please use the contact information below.
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable, but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy nor offer to sell securities, but is rather a paid advertisement provided for information purposes only and shouldn't be used as basis for investment decisions. MP isn't an investment advisor and this report isn't investment advice. MP has been paid $1,500 by Trilogy Capital on behalf of GDTI for preparation and distribution of this report and other advertising services. Additionally, MP and/or affiliates, associates and employees from time to time may have either a long or short position in any securities mentioned. This constitutes a conflict of interest as to MP's ability to remain objective in communication regarding subject companies.
The SmallCap Sentinel logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3664